openPR Logo
Press release

Global Oncolytic Virus Therapy Market Forecast to 2023 : Product Scope, Market Overview, Market Opportunities, Market Risk

03-14-2018 05:06 PM CET | Health & Medicine

Press release from: Research By Markets

Global Oncolytic Virus Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Global Oncolytic Virus Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023

Research By Markets Press Release, "Global Oncolytic Virus Therapy Market by Manufacturers, Countries, Type and Application, Forecast to 2023", 108 Pages, 8 Companies Profiled and 5 Global Key Markets Covered.

This report sheds light on the Oncolytic Virus Therapy in Global Market, especially in North America, Europe, Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, types and applications.

TOC and List of Tables & Figures: https://www.researchbymarkets.com/report/global-oncolytic-virus-therapy-market-by-manufacturers-countries-type-and-application-forecast-to-2023-11094.html

Market Segmentation by Manufacturers:
Amgen
Oncolytics Biotech
Viralytics
Transgene SA
Oncolys BioPharma
Targovax
PsiOxus Therapeutics
SillaJen Biotherapeutics
Sorrento Therapeutics
Lokon Pharma
Genelux Corporation
Vyriad
TILT Biotherapeutics
Cold Genesys

Access Sample Pages for this report: https://www.researchbymarkets.com/sample-request/11094

Market Segmentation by Regions:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segmentation by Applications:
Melanoma
Prostate Cancer
Breast Cancer
Ovarian Cancer
Others

Inquire more about this report: https://www.researchbymarkets.com/inquiry/11094

There are 15 Chapters to deeply display the global Oncolytic Virus Therapy market.

Chapter 1, to describe Oncolytic Virus Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oncolytic Virus Therapy, with sales, revenue, and price of Oncolytic Virus Therapy, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncolytic Virus Therapy, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oncolytic Virus Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oncolytic Virus Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source.

Contact:
ResearchByMarkets
Ms. Lia Seth | Client Relations Manager
enquiry@researchbymarkets.com

Research By Markets is an online Market Research Report Repository.

Our repository contains reports segmented by Geography and Industry. We cover all major Industry Verticals - Information Technology, Semiconductor, Electronics, Manufacturing, Food & Beverages, Telecommunications, Healthcare, Pharmaceutical, Automotive, BioTechnology, Energy & Power, Banking and many more.

Research By Markets
3, Nagar Road,
Pune 411 014, Maharashtra, India
enquiry@researchbymarkets.com
+1-800-416-3124

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Oncolytic Virus Therapy Market Forecast to 2023 : Product Scope, Market Overview, Market Opportunities, Market Risk here

News-ID: 978839 • Views:

More Releases from Research By Markets

V2X (Vehicle-to-Everything) Communications Ecosystem expected to grow at a CAGR of more than 170% between 2019 and 2022
V2X (Vehicle-to-Everything) Communications Ecosystem expected to grow at a CAGR …
Commonly referred to as V2X, vehicle-to-everything communications technology allows vehicles to directly communicate with each other, roadside infrastructure, and other road users to deliver an array of benefits in the form of road safety, traffic efficiency, smart mobility, environmental sustainability, and driver convenience. In addition, V2X is also helping pave the way for fully autonomous driving through its unique non line-of-sight sensing capability which allows vehicles to detect potential hazards,
Research By Markets - Trusted By Market Leaders
Research By Markets - Trusted By Market Leaders
Research By Markets is a Market Research Reports Online Repository. We have a huge database of syndicated market research reports that are segmented by Industry Verticals mainly - Telecommunication, Semiconductor, Electronics, Information Technology, Automotive, Healthcare, Pharmaceutical, Medical Devices, Biotechnology, Energy, Power, Aerospace, Defense, Consumer Goods, Construction, Equipment and many more. Our clientele includes Fortune listed companies who trust us to help them with their market intelligence requirements. Research By Markets being a
Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022) - ResearchByMarkets.com
Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022) - Rese …
The report titled "Global Veterinary Services Market: Size, Trends and Forecasts (2018-2022)", provides an in depth analysis of the global veterinary services market by value, by segments, by services, by region, etc. The report also provides a regional analysis of the veterinary services market, including the following regions: North America, Europe, Asia Pacific, Latin America and MEA. The report also assesses the key opportunities in the market and outlines the factors
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - ResearchByMarkets.com
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 - Researc …
Pancreatic and Bile Duct Cancer Drug Development Pipeline Review, 2018 Summary This report provides an overview of the pipeline landscape for pancreatic and bile duct cancer. It provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for pancreatic and bile duct cancer, and features dormant and discontinued products. Pancreatic cancer is a disease in which malignant (cancer) cells are found in the tissues of the pancreas, a

All 5 Releases


More Releases for Oncolytic

Prominent Oncolytic Virus Therapy Market Trend for 2025: Accelerating Oncolytic …
Which drivers are expected to have the greatest impact on the over the oncolytic virus therapy market's growth? The rise in cancer incidences is likely to fuel the expansion of the oncolytic virus therapy market. Oncolytic virus therapy is gaining traction as an appealing approach to treating cancer- a collection of diseases marked by abnormal cell growth and proliferation. This therapeutic strategy effectively targets and eliminates cancer cells, while also triggering
Enhancing the Immune Response with Oncolytic Virus Therapy
Oncolytic virus therapy is revolutionizing cancer treatment by harnessing the unique characteristics of viruses to specifically target and destroy cancer cells. This cutting-edge approach represents a significant advancement in cancer care, offering renewed hope for patients with different types of cancer. Download Report: https://www.kuickresearch.com/report-oncolytic-virus-immunotherapy-market-oncolytic-virus-therapy-market-oncolytic-virus-fda-approved-oncolytic-virus-clinical-trilas The essence of oncolytic virus therapy is based on genetically modified viruses that can selectively attack and kill cancer cells while leaving healthy tissue unharmed. These engineered viruses take
Creative Biolabs Unleashes Solutions to Validate Oncolytic Virotherapy
Creative Biolabs introduces safety and efficacy validation strategies for oncolytic virotherapy. New York, USA - June 17, 2024 - Oncolytic virotherapy appears as a new paradigm in cancer immunotherapy that enrolls specifically engineered viruses to selectively infect and kill cancer cells, some of which have marched into clinical trials, like adenoviruses, HSV, reovirus, vaccinia virus, and measles. With so many other candidates still on their preclinical journey, the requests to validate
Oncolytic Virus Competitive Landscape 2023 (Updated)
DelveInsight's, "Oncolytic Virus Competitive Landscape 2023" report provides comprehensive insights about 150+ Oncolytic Virus Companies and 175+ drugs in the Oncolytic Virus Competitive landscape. It covers the Oncolytic Virus therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this space. Key Takeaways from the Oncolytic Virus Competitive Landscape Report • DelveInsight's Oncolytic Virus report depicts a robust space with 150+ Oncolytic
Oncolytic Virus Therapy Market Oncolytic Virus Therapy Clinical Pipeline Report …
For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990 Report Table of Contents Prologue to Oncolytic Virus 1.1 Outline of Oncolytic Virotherapy 1.2 Trail from Genesis to Biogenetics Primer of Virotherapy in Malignancies 2.1 Oncolytic Viruses towards Cancer 2.2 Approaches for Targeting Tumor Cells 2.2.1 Pro Apoptotic Targeting 2.2.2 Translational Targeting 2.2.3 Transcriptional Targeting 2.2.4 Transductional Targeting Mechanism
Global Oncolytic Virus Therapy Report Highlight Market Opportunity & Insight On …
“Global Oncolytic Virus Therapy Market and Pipeline Outlook 2022” report analyzes ongoing clinical and non-clinical trends in the oncolytic virus therapy market. Currently there are 2 oncolytic virus therapies commercially available in the market. This report analyzes the ongoing clinical trial of 48 oncolytic virus therapies in clinical pipeline and gives comprehensive clinical insight on various parameters associated with the development of the oncolytic virus therapies. Most of the oncolytic